NMS-P937 (NMS1286937)
- CAS NO.:1034616-18-6
- Empirical Formula: C24H27F3N8O3
- Molecular Weight: 532.52
- MDL number: MFCD26793840
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:00
What is NMS-P937 (NMS1286937)?
The Uses of NMS-P937 (NMS1286937)
NMS-P937 is a quinazoline derivative that is a potent and selective Polo-like kinase 1 inhibitor. Antitumor, anti-cancer.
Biological Activity
nms-1286937 (nms-p937) is a potent and selective inhibitor of polo-like kinase 1 (plk1) with ic50 value of 2 nm [1].plk1 is a serine/threonine protein kinase and plays an important role in the cell cycle control machinery. plk1 is involved in mitotic entry, bipolar mitotic spindle formation, centrosome duplication, transition from metaphase to anaphase, maintenance of genomic stability and cytokinesis [1].nms-1286937 is an orally bioavailable plk1 inhibitor. in cell lines established from solid tumors, leukemias and lymphomas, nms-p937 inhibited tumor cell proliferation. in a2780 cells, nms-p937 caused a g2-m cell-cycle block. in the mitotic phase, nms-p937 induced apoptotic death with misaligned chromosomes and an aberrant number of spindles poles [2]. in human osteosarcoma (os) cell lines, nms-p937 inhibited migration and clonogenic ability of cell lines. in abcb1-overexpressing, doxorubicin (dx)-resistant cell lines, combination of nms-p937 and dx reverted dx-resistance by inhibiting abcb1 transport activity [3].in harlan nu/nu mice, nms-p937 exhibited a good pharmacokinetic profile with low clearance, high auc and cmax, and acceptable oral bioavailability. in mice xenografted with human hct116 colon adenocarcinoma cells, nms-p937 (45 mg/kg) inhibited tumor growth by 83% and reduced body weight by 16% [1].
References
[1]. beria i, bossi rt, brasca mg, et al. nms-p937, a 4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline derivative as potent and selective polo-like kinase 1 inhibitor. bioorg med chem lett, 2011, 21(10): 2969-2974.
[2]. valsasina b, beria i, alli c, et al. nms-p937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies. mol cancer ther, 2012, 11(4): 1006-1016.
[3]. sero v, tavanti e, vella s, et al. targeting polo-like kinase 1 by nms-p937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance. invest new drugs, 2014, 32(6): 1167-1180.
Properties of NMS-P937 (NMS1286937)
Boiling point: | 757.8±70.0 °C(Predicted) |
Density | 1.57±0.1 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL in DMSO |
form | solid |
pka | 14.29±0.10(Predicted) |
color | Off-white to light yellow |
Safety information for NMS-P937 (NMS1286937)
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation |
Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. P332+P313:IF SKIN irritation occurs: Get medical advice/attention. P337+P313:IF eye irritation persists: Get medical advice/attention. |
Computed Descriptors for NMS-P937 (NMS1286937)
New Products
6-Bromo 2-Iodo Indole Pyridine 2,4,6-Tricarboxaldehyde Fosfomycin EP impurity D Ivermectin EP Impurity B Rimegepant Impurity 3 Tubulysin G Tubulysin A Tubulysin I Tubulysin M (R)-tert-butyl (4-methyl-1-oxopentan-3-yl)carbamate Potassium HMDS (1.0 M in THF) (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine 2-(1-(Mercaptomethyl) cyclopropyl) acetonitrile Fuel shell 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol ethanedioate Imeglimin Hydrochloride IH Calcium Sodium Phosphosilicate IH 4,8-dibromo-5H-[1,2,3]triazolo[4',5':4,5]benzo[1,2-c][1,2,5]thiadiazole Methyl 4-amino-3-(4-phenylpiperazin-1-yl)benzoate (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate 4,7-Dibromobenzo[c][1,2,5]thiadiazole-5,6-diamine (1-Isopropyl-1H-pyrazol-5-yl)boronic acid 3,6-Bis(4-iodophenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione 5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrileRelated products of tetrahydrofuran
You may like
-
3,6-Bis(4-iodophenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dioneView Details
952145-70-9 -
1262243-12-8View Details
1262243-12-8 -
Rimegepant Impurity 3View Details
-
Sidchem 730View Details
-
Sidchem BT 20View Details
-
1572177-89-9View Details
1572177-89-9 -
6390-09-6View Details
6390-09-6 -
6-Bromo indoleView Details